Economic Development

transOMIC technologies Releases Tagged ORF Clones for Protein Expression

News Outlet: 
PRWeb
Date published: 
January 29, 2013

Huntsville, AL (PRWEB) January 29 -- TransOMIC technologies announced today that it has partnered with Clontech (a Takara Bio company) to launch the MGC premier™ Tagged ORF collections for gene and protein analysis. Over 40,000 human, mouse and rat genes are represented in these new genome-scale ORF collections, making transOMIC technologies the largest provider of gene content for protein expression.
 

Jim Hudson named among Alabama image enhancers

News Outlet: 
Business Alabama Magazine
Date published: 
January 2, 2013

No one has done more to push Alabama’s image as a leader in biotechnology than Huntsville’s Jim Hudson, one of the founders of the HudsonAlpha Institute for Biotechnology.

transOMIC technologies

transOMIC technologies is focused on providing the life science research market with innovative technologies and research tools to accelerate the quest towards elucidating the complexity of  life and human disease. These research tools for gene manipulation provide investigators with standardized high-quality genes, RNAi and delivery reagents for interrogating gene function in relation to oncology, neuroscience and metabolic disorders. Our product portfolio is developed through close collaborations with the world’s leading research institutes, enabling rapid commercialization of next generation tools and technologies to make them broadly accessible to the research community.

CFDRC developing cell-based microchip to study drug interactions

 

HUNTSVILLE, Ala. - CFD Research Corporation, CFDRC, has been awarded a $1.3M grant from the National Institutes of Health to further develop their novel in vitro Blood-Brain Barrier model. Building upon CFDRC’s patented and commercially available SynVivo platform, SynVivo-BBB is a cell-based microchip which allows co-culture of endothelial cells under physiological flow with neuronal and glial cells mimicking the in vivo environment.
 
Download PDF: 

Food Security Group

The Food Security Group is dedicated to meeting the challenge of producing sufficient food to feed the world’s expanding population through the commercialization and proliferation of advanced agricultural technologies. The group works primarily with companies focused on advanced fertilizers,  seed and plant genetics, water utilization, pest and disease control and post harvest efficiency. The Food Security Group actively collaborates with subject matter experts and issue advocates, including leading not-for-profit entities committed to alleviating poverty in developing nations, in order to fully address agricultural efficiency solutions.

IDair

IDair provides rapid, touchless fingerprint collection products. The mission of IDair is to provide a product that allows security systems to acquire fingerprints with ease while improving the quality of identity protection. IDair is a spin-off from Advanced Optical Systems, Inc., a Huntsville company with more than 20 years of experience in specialized sensors for the DoD and NASA markets.

HudsonAlpha announces expansion on biotechnology campus

Alabama Governor Robert Bentley to join HudsonAlpha and local officials for groundbreaking ceremony

 

HUNTSVILLE, Ala. - Governor Robert Bentley will be on hand this morning, June 15, to acknowledge the state’s ongoing dedication to the HudsonAlpha Institute for Biotechnology and expansion of the life sciences industry in Alabama.  “The addition of a new facility on the Cummings Research Park Biotech Campus creates opportunities to significantly enrich the state’s knowledge worker economy,” said Bentley.  Bentley will join HudsonAlpha co-founder Jim Hudson to announce construction of a third building on the campus.

Southern Cord

Southern Cord™ is a private cord blood banking service established to make cord blood banking affordable, as well as to educate expectant families on the potential benefits of banking their child’s cord blood. Cord blood is the blood remaining in the umbilical cord and placenta of a newborn baby, following delivery. Close to 80 diseases and disorders are currently treatable with stem cells from a baby’s cord blood.

FDA Awards EGEN, Inc. Orphan -Drug Grant for Clinical Development of EGEN-001 for Treatment of Ovarian Cancer

News Outlet: 
PR Newswire
Date published: 
February 2, 2011
Download PDF: 

HUNTSVILLE, Ala., Feb. 2, 2011 /PRNewswire/ -- EGEN, Inc. today announced that the Food and Drug Administration (FDA) has awarded the company a four-year grant of $1,600,000 to assist in the Phase II clinical development of EGEN-001, the company's lead product. EGEN-001 is under clinical development for the treatment of advanced recurrent ovarian cancer.  EGEN has successfully completed two Phase I trials of EGEN-001 in ovarian cancer patients.

Biotech company iXpressGenes creating new DNA for research at Huntsville's HudsonAlpha Institute

News Outlet: 
The Huntsville Times
Date published: 
February 1, 2011
Download PDF: 

By Lee Roop
Photo credit: Eric Schultz, The Huntsville Times

Dr. Joe NgHUNTSVILLE, Ala. - A Huntsville startup company is using the emerging science of synthetic biology to create "biological Legos" scientists can use to modify living organisms. Dr. Joseph Ng's company, iXpressGenes, is making genes "from scratch" now in a laboratory at HudsonAlpha Institute for Biotechnology. "Scratch" is the key word, Ng said last week. "Instead of cutting and pasting existing genes, we are creating new ones," Ng said.

Syndicate content